JNJ

Pounce on Abbott While It's Down
Pounce on Abbott While It's Down
Yahoo/Real Money
Abbott Laboratories
GSK
JNJ
Flag link:
Paired Trade: Sell Allergan, Buy Johnson & Johnson
Paired Trade: Sell Allergan, Buy Johnson & Johnson
Seeking Alpha
Allergan
JNJ
Flag link:
Baxter 1Q profit rises 20 percent, but sales fall
Baxter 1Q profit rises 20 percent, but sales fall
Yahoo/AP
Baxter International
devices
earnings
Abbott Laboratories
JNJ
Flag link:
J&J shelves plans for separate wellness unit: report
J&J shelves plans for separate wellness unit: report
Yahoo/AP
JNJ
Flag link:
Abbott's on Sale
Abbott's on Sale
Motley Fool
Abbott Laboratories
JNJ
Amgen
Wyeth
Boston Scientific
Flag link:
J&J CFO Says Slump’s Effect on Company Won’t Worsen
J&J CFO Says Slump’s Effect on Company Won’t Worsen
Bloomberg
JNJ
Flag link:
J&J Tops Profit Forecast, Confirms Outlook
J&J Tops Profit Forecast, Confirms Outlook
CNBC
JNJ
earnings
Flag link:
Will These Drugs Get Past the FDA?
Will These Drugs Get Past the FDA?
Motley Fool
FDA
PDUFA
Savient
Medicis
Discovery Labs
Schering Plough
JNJ
Novo Nordisk
AstraZeneca
Flag link:
Partners J&J, Schering-Plough get first approval for promising biologic arthritis drug
Partners J&J, Schering-Plough get first approval for promising biologic arthritis drug
Yahoo/AP
JNJ
Schering Plough
arthritis
Canada
Flag link:
Defensive pharma promises solid Q1 results
Defensive pharma promises solid Q1 results
Yahoo/Reuters
Abbott Laboratories
JNJ
Merck
Flag link:
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
Seeking Alpha
JNJ
Merck
Pfizer
Schering Plough
Flag link:
J&J expected to report lower earnings
J&J expected to report lower earnings
Marketwatch
JNJ
earnings
Flag link:
Cash: The Cure for Smaller Drugmakers
Cash: The Cure for Smaller Drugmakers
Motley Fool
Merck
Cardiome
partnerships
GSK
Bristol-Myers Squibb
JNJ
Flag link:
J&J to eliminate 900 positions, mostly sales
J&J to eliminate 900 positions, mostly sales
Yahoo/Reuters
JNJ
layoffs
Flag link:
J&J Warns Against Quick Approvals for Biotech Copies
J&J Warns Against Quick Approvals for Biotech Copies
Bloomberg
JNJ
drug approvals
patents
generics
Flag link:
At $18 Million, Abbott CEO’s Pay Tops Pfizer, Merck, J&J Chiefs
At $18 Million, Abbott CEO’s Pay Tops Pfizer, Merck, J&J Chiefs
WSJ Online
Pharma CEOs
Abbott Laboratories
Pfizer
Merck
JNJ
Flag link:
Merck to Benefit in SGP Deal
Merck to Benefit in SGP Deal
Yahoo/Zacks.com
Merck
Schering Plough
buyouts
Remicade
JNJ
Flag link:
J&J, Watson weigh options after court rules patent on J&J ADHD drug Concerta is invalid
J&J, Watson weigh options after court rules patent on J&J ADHD drug Concerta is invalid
Yahoo/AP
JNJ
Watson Pharmaceuticals
ADHD
patents
Concerta
Flag link:
Pharma's Refreshing Bad News
Pharma's Refreshing Bad News
Motley Fool
drug trials
Schering Plough
AstraZeneca
Eli Lilly
JNJ
Pfizer
Flag link:
J&J wants a piece of Merck/Schering action
J&J wants a piece of Merck/Schering action
Fierce Pharma
JNJ
Merck
Schering Plough
buyouts
Flag link:

Pages